Bridgefront Capital, LLC Astrazeneca PLC Transaction History

Bridgefront Capital, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$66.81 - $80.83 $236,440 - $286,057	3,539 New	3,539 $276,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $195,047 - $253,443	3,598 New	3,598 $243,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $777,904 - $897,987	-16,495 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $800,337 - $957,039	16,495 New	16,495 $825,000

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Bridgefront Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgefront Capital, LLC with notifications on news.